Vimarsana
Biggest News Aggregation in the World

Page 8 - Bruce Strober News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bruce Strober. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bruce Strober Today - Breaking & Trending Today

Durable and Deepening Clinical Responses Observed in Post-Treatment Period of Evelo ... - Vimarsana News

Durable and Deepening Clinical Responses Observed in Post-Treatment Period of Evelo ...

-18/30 patients maintained a PASI-50 or greater response at 24 weeks post-treatment- -9/20 patients experienced a deepening of response from PASI-50 to at least PASI-75 during post-treatment period- -No flare

Source: kulr8.com
18 Things You Should Know About Palmoplantar Psoriasis - Vimarsana News

18 Things You Should Know About Palmoplantar Psoriasis

Palmoplantar psoriasis is a type of psoriasis on your palms and soles of your feet that can be especially difficult to treat. But there are ways to get this challenging condition under control. The post 18 Things You Should Know About Palmoplantar Psoriasis appeared first on The Healthy.

Source: msn.com
10 Ways to Deal With Psoriasis in Your Ears - Vimarsana News

10 Ways to Deal With Psoriasis in Your Ears

Ear psoriasis can impair your hearing if it spreads to your ear canal. Learn about its symptoms, treatments, and how to prevent hearing loss. The post 10 Ways to Deal With Psoriasis in Your Ears appeared first on The Healthy.

Source: msn.com
Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021 - Vimarsana News

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021 Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that two abstracts from Dermavant's two pivotal Phase 3 trials for tapinarof for the treatment of psoriasis in adults, PSOARING 1 and PSOARING 2, will be presented during the upcoming American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), on April 23-25, 2021. Tapinarof is being developed as a novel, once-daily th...

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentation at the Innovations in Dermatology Conference - Vimarsana News

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentation at the Innovations in Dermatology Conference

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentation at the Innovations in Dermatology Conference Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that an abstract containing interim analysis data from Dermavant's PSOARING 3 long-term, open-label safety study for tapinarof for the treatment of psoriasis in adults will be presented in poster format during the upcoming Innovations in Dermatology Virtual Spring Conference 2021, held from March 16-20, 2021. The f...